Norman Schwartz's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 11,671 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 11,671 | 11,671 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 13,822 | 13,822 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 3,005 | 435,925 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 3,005 | 9,015 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,320 | 439,479 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,320 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,081 | 436,399 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,081 | 4,164 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,805 | 438,124 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,805 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 1,607 | 434,318 (1%) | 0% | 337.3 | 542,073 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,266 | 1,266 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,266 | 436,864 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 1,241 | 438,238 (1%) | 0% | 334.3 | 414,879 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 965 | 437,159 (1%) | 0% | 337.3 | 325,514 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 801 | 435,598 (1%) | 0% | 337.3 | 270,193 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 545 | 436,319 (1%) | 0% | 337.3 | 183,839 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 13,006 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 57 | 361,466 (7%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 14,137 | 14,137 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 12,949 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Schwartz Norman | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 49 | 361,409 (7%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.80 per share. | 01 Nov 2023 | 35,000 | 380,300 (7%) | 0% | 119.8 | 4,193,000 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 35,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 25,642 | 354,658 (6%) | 0% | 273 | 7,000,266 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.56 per share. | 01 Nov 2023 | 16,000 | 370,658 (7%) | 0% | 139.6 | 2,232,960 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 16,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 01 Nov 2023 | 15,000 | 373,384 (7%) | 0% | 159.3 | 2,389,800 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2023 | 15,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 12,274 | 358,384 (7%) | 0% | 273 | 3,350,802 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.00 per share. | 01 Nov 2023 | 12,024 | 361,360 (7%) | 0% | 273 | 3,282,552 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 12,020 | 12,020 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.50 per share. | 25 Aug 2023 | 39,000 | 370,689 (7%) | 0% | 117.5 | 4,582,500 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 39,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 25,389 | 345,300 (6%) | 0% | 381.8 | 9,693,012 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,600 | 434,210 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,320 | 432,761 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,320 | 2,320 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,081 | 6,245 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 2,081 | 429,925 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,805 | 431,336 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,805 | 1,805 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,290 | 432,920 (1%) | 0% | 381.8 | 492,496 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,266 | 2,532 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 1,266 | 430,159 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,151 | 431,610 (1%) | 0% | 381.8 | 439,429 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 1,032 | 428,893 (1%) | 0% | 381.8 | 393,997 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 895 | 430,441 (1%) | 0% | 381.8 | 341,693 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 381.78 per share. | 25 Aug 2023 | 628 | 429,531 (1%) | 0% | 381.8 | 239,758 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 12,900 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Nov 2022 | 42 | 331,689 (6%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 2,600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 429,419 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,600 | 428,394 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,319 | 4,640 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 2,319 | 427,199 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 1,805 | 3,610 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 1,805 | 425,974 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,575 | 427,844 (1%) | 0% | 478.3 | 753,354 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,575 | 426,819 (1%) | 0% | 478.3 | 753,354 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,405 | 425,794 (1%) | 0% | 478.3 | 672,040 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 1,094 | 424,880 (1%) | 0% | 478.3 | 523,282 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 8,326 | 8,326 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 1,266 | 424,936 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 1,266 | 3,798 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 767 | 424,169 (1%) | 0% | 486.3 | 372,954 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2022 | 39,250 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 107.32 per share. | 26 Aug 2022 | 39,250 | 355,396 (6%) | 0% | 107.3 | 4,212,310 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 495.28 per share. | 26 Aug 2022 | 23,749 | 331,647 (6%) | 0% | 495.3 | 11,762,405 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2021 | 20 | 12,858 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Nov 2021 | 20 | 316,146 (6%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 37,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 100.06 per share. | 07 Sep 2021 | 37,000 | 336,786 (6%) | 0% | 100.1 | 3,702,220 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 806.32 per share. | 07 Sep 2021 | 20,660 | 316,126 (6%) | 0% | 806.3 | 16,658,571 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,000 | 301,274 (5%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,000 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 806.32 per share. | 07 Sep 2021 | 1,488 | 299,786 (5%) | 0% | 806.3 | 1,199,804 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,600 | 2,600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,600 | 5,200 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,600 | 424,960 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,600 | 423,650 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,319 | 6,959 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 2,319 | 422,200 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 1,290 | 423,670 (1%) | 0% | 819.7 | 1,057,413 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 1,290 | 422,360 (1%) | 0% | 819.7 | 1,057,413 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 1,150 | 421,050 (1%) | 0% | 819.7 | 942,655 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 5,064 | 5,064 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 5,064 | 5,064 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 1,805 | 5,415 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 1,805 | 420,776 (1%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 01 Sep 2021 | 895 | 419,881 (1%) | 0% | 825.8 | 739,064 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2020 | 27 | 298,274 (5%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Dec 2020 | 27 | 12,838 (0%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 3,200 | 299,834 (5%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 3,200 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.02 per share. | 11 Sep 2020 | 1,587 | 298,247 (5%) | 0% | 505.0 | 801,467 | Bio-Rad B Common Stock |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 3,000 | 298,122 (5%) | 0% | 0 | Bio-Rad B Common Stock | |
| Bio-Rad Laboratories Inc. ... | Norman Schwartz | Director, Chairman, President, and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 2,600 | 418,951 (1%) | 0% | 0 | Bio-Rad A Common Stock |